Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on August 11, 2026

Aug. 11, 2026

TOTWOO Launches AI-Powered Smart Locket in the U.S., Expanding Its Connected Jewelry Portfolio

Indeterminate GlobeNewswire

Aug. 11, 2026

Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders

Indeterminate GlobeNewswire

Aug. 11, 2026

 Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or…

Indeterminate GlobeNewswire

Aug. 11, 2026

Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)

Indeterminate GlobeNewswire

Aug. 11, 2026

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States

Indeterminate GlobeNewswire

Aug. 11, 2026

Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 11, 2026

Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth

Indeterminate GlobeNewswire

Aug. 11, 2026

US Beauty Industry Posts Solid First-Half Growth as Fragrance and Skincare Lead Across Prestige and Mass Retail, Circana Reports

Indeterminate GlobeNewswire

Aug. 11, 2026

Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma

Indeterminate GlobeNewswire

Aug. 11, 2026

Constant Therapy Health Launches Web Platform for Speech, Language, and Cognitive Therapy

Indeterminate GlobeNewswire

Aug. 11, 2026

NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth

Indeterminate GlobeNewswire

Aug. 11, 2026

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)

Indeterminate GlobeNewswire

Aug. 11, 2026

Modern Haus Dental's Dr. Kristy Lee Recognized as Top Dentist by Bethesda Magazine for Third Consecutive Year

Indeterminate GlobeNewswire

Aug. 11, 2026

Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

Indeterminate GlobeNewswire

Aug. 11, 2026

Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer

Indeterminate GlobeNewswire

Aug. 11, 2026

Breckenridge Distillery Turns Colorado’s Famous Palisade Peaches into a Fresh Pour of Summer with New Peach Whiskey

Indeterminate GlobeNewswire

Aug. 11, 2026

Harvard Bioscience Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire